insulin vs glp-1 What is GLP-1? The Hormone Powering Weight Loss Medications – Revolution Health & Wellness Adjusting Your Insulin Pump When

announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding In August 2025, Novo Nordisk cirrhosis , in combination with diet and exercise

These medications offer a modern solution that targets both appetite regulation and metabolic processes, potentially leading to significant weight loss for certain individuals

In clinical trials, patients lost 12 percent of their body weight on average, in line with the original Ozempic injection, but a smidge lower than Mounjaro, Zepbound, and some of the more recent entries into this drug class

Jazmin Aguilera: But theres no other downside

And yep, nuut fits right into that game plan

In June 2025, MBX Biosciences announced that it has submitted an IND application to the FDA for MBX 4291, a long-acting GLP-1/GIP receptor co-agonist prodrug targeting obesity, which received regulatory clearance in July